Comparative Mechanisms of Genomic Instability
基因组不稳定性的比较机制
基本信息
- 批准号:7477100
- 负责人:
- 金额:$ 35.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedB-Cell LymphomasB-DNABenzo(a)pyreneBurkitt LymphomaCandidate Disease GeneCellsCharacteristicsChromatinChromosomal RearrangementChromosomal translocationChromosome BreakageChromosome Fragile SitesChromosomesClassificationComplementDNADNA AdductionDNA AdductsDNA DamageDNA Double Strand BreakDNA Modification ProcessDNA SequenceDNA StructureDNA lesionDNA-Binding ProteinsDataDevelopmentDiseaseEndogenous FactorsEnvironmental CarcinogensEnvironmental ExposureEnvironmental ImpactEnvironmental PollutionEnvironmental Risk FactorEnzymesEpoxy CompoundsExcisionExposure toFrequenciesGenesGeneticGenetic Predisposition to DiseaseGenetic ProcessesGenetic RecombinationGenetic RiskGenomeGenomic InstabilityGenomicsGlycolGoalsH-DNAHumanHuman Cell LineIndiumInduced MutationKnock-outLeadLesionMYC geneMalignant - descriptorMalignant NeoplasmsMammalian CellMeasuresMismatch RepairMolecular ConformationMusMutagenesisMutationNucleotide Excision RepairNumbersOncogenicPathogenesisPathway interactionsPlasmidsPlayPoint MutationPredispositionPreventionProcessProtein OverexpressionProteinsRadiation GeneticsRateReporterReporter GenesResearch PersonnelResistanceRisk FactorsRoleSamplingScreening procedureSeriesSkinSmall Interfering RNAStructureSunlightSystemTechniquesTestingTransgenic OrganismsTranslocation BreakpointYeastsZ-Form DNAadductbasechromosome mutationcomparativedisorder controldisorder riskenvironmental agenthigh throughput screeninghuman diseasein vivointernal controlirradiationleukemia/lymphomamouse modelmutantnovelnovel strategiesprogramsrepairedresearch studyultraviolet irradiationvector
项目摘要
DESCRIPTION (provided by applicant):
Chromosomal translocations resulting in inappropriate control of disease-related genes are important causative factors in environmentally induced disorders such as cancer. For example, translocations resulting in overexpression of the BCL-2 and c-MYC genes are the hallmarks of follicular B-cell lymphoma and Burkitt's lymphoma, respectively. DNA double-strand breaks (DSBs) are the first step in the process of chromosomal translocation. However, little is known about the mechanism(s) of the breakages on the translocated genes, why the DSBs tend to locate in certain genomic fragile site "hotspots", and the effects of environmental agents on the genomic instability at these susceptible hotspots. In this application, the intent is to use a comparative genetic approach to determine mechanisms of DNA structure-induced genomic instability. Interestingly, the most common breakpoints in such genes occur near regions that are capable of adopting non-B DNA structures. This group has discovered that H-DNA and Z-DNA-forming sequences near the translocation breakpoint hotspots in the human c-MYC gene induce DSBs, resulting in high levels of genetic instability in mammalian cells. Hence, the objectives of this application are to determine the mechanisms involved in genetic instabilities at breakpoint hotspots associated with disease, and further the development of novel approaches to reduce genetic instability caused by environmental DNA damaging agents. The immediate goals are to test the hypotheses that non-B-DNA structures found in the BCL-2 and c-MYC breakpoint regions are implicated in genetic instability across species, and that DNA damage induced by environmental factors at these hotspots enhance their susceptibility to genomic instability. The following are proposed: 1) to measure non-B DNA-induced genetic instability in different species. The naturally occurring H-DNA or Z-DNA-forming sequences from the human c-MYC and BCL-2 genes will be screened for their mutagenic potentials in a variety of species including yeast, mouse, and human. DNA structure-induced DSBs, illegitimate recombination, or point mutations in cells will be detected by facile blue/white screening; 2) to determine the susceptibility of non-B DNA-sequences to environmental carcinogen-induced DNA damage and mutagenesis. Environmental carcinogens such as irradiation are known to result in more non-B structure formation, and a reduced error-free repair of the damage. Thus, the amount of DNA damage induced and repaired in non-B sequences will be measured, and the level of genetic instability induced by environmental agents at these fragile site "hotspots" determined; and 3) to identify the genes/pathways that are involved in the genetic instability at non-B DNA sequences in the presence and absence of environmental carcinogens. Using a high-throughput screen gene products involved in DNA structure-induced genetic instability will be identified at genomic hotspots to begin to elucidate the pathways involved in genetic instability. Data obtained will give a better understanding of the mechanisms of genomic instability and the impact of environmental agents on these mechanisms. These discoveries should begin to unravel the pathogenesis of diseases that are caused by genomic instability, and ultimately to the development of new approaches for treatment and prevention.
描述(由申请人提供):
染色体易位导致疾病相关基因的不适当控制是癌症等环境诱发疾病的重要致病因素。例如,导致bcl2和c-myc基因过度表达的易位分别是滤泡性B细胞淋巴瘤和Burkitt淋巴瘤的特征。DNA双链断裂(DSB)是染色体易位过程的第一步。然而,关于易位基因断裂的机制(S)、为什么双链断裂倾向于位于某些基因组脆性部位的热点以及环境因素对这些易位基因的不稳定性的影响,人们知之甚少。在这项应用中,目的是使用比较遗传学的方法来确定DNA结构诱导的基因组不稳定的机制。有趣的是,这类基因中最常见的断裂点发生在能够采用非B DNA结构的区域附近。该小组发现,人类c-myc基因易位断裂点附近的H-DNA和Z-DNA形成序列会诱导DSB,导致哺乳动物细胞高度的遗传不稳定性。因此,这项应用的目标是确定与疾病相关的断点热点处的遗传不稳定性所涉及的机制,并进一步开发新的方法来减少环境DNA损伤剂引起的遗传不稳定性。目前的目标是检验这样的假设,即在bcl2和c-myc断点区发现的非B-DNA结构与物种间的遗传不稳定有关,并且这些热点上的环境因素引起的DNA损伤增加了它们对基因组不稳定的易感性。建议如下:1)测量非B DNA在不同物种中引起的遗传不稳定性。来自人类c-myc和bcl2基因的自然产生的H-DNA或Z-DNA形成序列将在包括酵母、小鼠和人类在内的各种物种中筛选其诱变潜力。DNA结构诱导的双链断裂、非法重组或细胞中的点突变将通过简便的蓝/白筛选来检测;2)确定非B DNA序列对环境致癌物诱导的DNA损伤和突变的敏感性。众所周知,辐射等环境致癌物会导致更多非B结构的形成,并减少损伤的无错误修复。因此,将测量在非B-DNA序列中诱导和修复的DNA损伤量,并确定在这些脆弱部位的环境因素诱导的遗传不稳定性的水平;以及3)确定在存在和不存在环境致癌物的情况下,与非B-DNA序列的遗传不稳定性有关的基因/途径。利用高通量筛选,DNA结构诱导的遗传不稳定性相关基因产物将在基因组热点处被鉴定,以开始阐明参与遗传不稳定性的途径。获得的数据将使我们更好地理解基因组不稳定的机制以及环境因素对这些机制的影响。这些发现应该开始揭开由基因组不稳定引起的疾病的发病机制,并最终发展出新的治疗和预防方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen M Vasquez其他文献
DNA interstrand crosslinks: Repair, cell signaling, and therapeutic implications
DNA 链间交联:修复、细胞信号传导和治疗意义
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:2.8
- 作者:
Karen M Vasquez;R. Legerski - 通讯作者:
R. Legerski
Karen M Vasquez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen M Vasquez', 18)}}的其他基金
Project 2: Error-free and Mutagenic Processing of Crosslinks
项目 2:交联的无差错和诱变处理
- 批准号:
9148675 - 财政年份:2017
- 资助金额:
$ 35.84万 - 项目类别:
Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots
短反向重复序列对突变热点遗传不稳定性的影响
- 批准号:
8756978 - 财政年份:2014
- 资助金额:
$ 35.84万 - 项目类别:
Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots
短反向重复序列对突变热点遗传不稳定性的影响
- 批准号:
8889235 - 财政年份:2014
- 资助金额:
$ 35.84万 - 项目类别:
Recognition and processing of complex lesions by components from multiple DNA
通过多种 DNA 成分识别和处理复杂病变
- 批准号:
8403932 - 财政年份:2004
- 资助金额:
$ 35.84万 - 项目类别:
Processing Site-Specific DNA Lesions by DNA Repair/Recom
通过 DNA 修复/重组处理位点特异性 DNA 损伤
- 批准号:
6990365 - 财政年份:2004
- 资助金额:
$ 35.84万 - 项目类别:
Recognition and processing of complex lesions by components from multiple DNA
通过多种 DNA 成分识别和处理复杂病变
- 批准号:
7781951 - 财政年份:2004
- 资助金额:
$ 35.84万 - 项目类别:
相似海外基金
Roles of immune cells derived from clonal hematopoiesis in B-cell lymphomas
克隆造血来源的免疫细胞在 B 细胞淋巴瘤中的作用
- 批准号:
24K19213 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identification of novel biomarkers for EBV-associated B-cell lymphomas arising in the oral cavity
口腔中出现的 EBV 相关 B 细胞淋巴瘤的新型生物标志物的鉴定
- 批准号:
23K15982 - 财政年份:2023
- 资助金额:
$ 35.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Chromunities Drive Transcriptional Reprogramming in Humoral Immunity and B-cell Lymphomas
染色体驱动体液免疫和 B 细胞淋巴瘤中的转录重编程
- 批准号:
10606730 - 财政年份:2023
- 资助金额:
$ 35.84万 - 项目类别:
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
- 批准号:
10566833 - 财政年份:2023
- 资助金额:
$ 35.84万 - 项目类别:
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
- 批准号:
10987699 - 财政年份:2023
- 资助金额:
$ 35.84万 - 项目类别:
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
HIV 感染者 EBV 阳性弥漫性大 B 细胞淋巴瘤的合成致死靶向
- 批准号:
10541285 - 财政年份:2022
- 资助金额:
$ 35.84万 - 项目类别:
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas
Epstein-Barr病毒LMP2A蛋白在维持EBV B细胞淋巴瘤中致癌IgM信号传导中的作用
- 批准号:
10540952 - 财政年份:2022
- 资助金额:
$ 35.84万 - 项目类别:
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
HIV 感染者 EBV 阳性弥漫性大 B 细胞淋巴瘤的合成致死靶向
- 批准号:
10703446 - 财政年份:2022
- 资助金额:
$ 35.84万 - 项目类别:
Therapeutic potential of novel antibody-oligonucleotide conjugate for intractable B-cell lymphomas
新型抗体-寡核苷酸缀合物治疗难治性 B 细胞淋巴瘤的潜力
- 批准号:
22K08497 - 财政年份:2022
- 资助金额:
$ 35.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomas
Epstein-Barr病毒LMP2A蛋白在维持EBV B细胞淋巴瘤中致癌IgM信号传导中的作用
- 批准号:
10707312 - 财政年份:2022
- 资助金额:
$ 35.84万 - 项目类别: